Rock Springs Capital Management LP - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$67,074,010
-11.8%
2,710,061
+0.9%
1.80%
-0.7%
Q2 2023$76,072,249
+24.4%
2,686,167
+0.9%
1.81%
+24.1%
Q1 2023$61,137,067
-27.3%
2,661,605
-11.2%
1.46%
-28.0%
Q4 2022$84,144,303
-2.7%
2,996,592
-2.0%
2.02%
-9.4%
Q3 2022$86,477,000
+33.2%
3,057,869
+4.4%
2.23%
+18.3%
Q2 2022$64,924,000
-16.3%
2,928,458
+9.9%
1.89%
-3.3%
Q1 2022$77,586,000
-10.8%
2,665,275
+0.7%
1.95%
-2.8%
Q4 2021$86,995,000
-26.3%
2,646,625
+3.5%
2.01%
-19.0%
Q3 2021$117,968,000
-16.8%
2,556,179
-0.7%
2.48%
-11.6%
Q2 2021$141,870,000
+8.0%
2,574,308
+1.2%
2.80%
-2.2%
Q1 2021$131,352,000
+20.1%
2,543,600
+0.8%
2.87%
+23.6%
Q4 2020$109,344,000
+97.5%
2,523,521
+59.6%
2.32%
+65.1%
Q3 2020$55,353,000
-12.3%
1,581,509
+34.1%
1.40%
-18.9%
Q2 2020$63,091,000
+68.5%
1,179,720
+11.8%
1.73%
+11.8%
Q1 2020$37,449,000
+22.3%
1,055,500
+64.5%
1.55%
+59.9%
Q4 2019$30,632,000
+168.2%
641,500
+82.0%
0.97%
+112.7%
Q3 2019$11,421,000
+34.3%
352,500
+106.7%
0.46%
+47.7%
Q2 2019$8,505,000
+7.3%
170,500
+45.1%
0.31%
+0.7%
Q1 2019$7,924,000117,5000.31%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders